Fund Holdings — Exome Asset Management LLC

Total Portfolio Value
$111.65M
Total Bought
$41.98M
Total Sold
$60.77M
Net Transaction
-$18.79M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ASTRAZENECA PLC(AZN)032,534+32,53404,7264.23%+4,726
COGENT BIOSCIENCES INC(COGT)0621,678+621,67803,7243.34%+3,724
VIRIDIAN THERAPEUTICS INC(VRDN)0217,294+217,29402,9292.62%+2,929
REGENXBIO INC(RGNX)0405,281+405,28102,8982.60%+2,898
DYNE THERAPEUTICS INC(DYN)0258,391+258,39102,7032.42%+2,703
REPLIMUNE GROUP INC(REPL)54,738294,846+240,1086632,8752.57%+2,212
ANAPTYSBIO INC0116,623+116,62302,1681.94%+2,168
TRAVERE THERAPEUTICS INC(TVTX)0118,017+118,01702,1151.89%+2,115
GE HEALTHCARE TECHNOLOGIES I(GEHC)025,400+25,40002,0501.84%+2,050
IONIS PHARMACEUTICALS INC(IONS)61,367135,616+74,2492,1454,0923.66%+1,946
IMMUNOME INC(IMNM)0263,841+263,84101,7761.59%+1,776
CRINETICS PHARMACEUTICALS IN(CRNX)051,295+51,29501,7201.54%+1,720
CORBUS PHARMACEUTICALS HLDGS(CRBP)0289,690+289,69001,5381.38%+1,538
AKERO THERAPEUTICS INC68,60876,379+7,7711,9093,0922.77%+1,183
CYTOKINETICS INC(CYTK)65,883103,483+37,6003,0994,1593.73%+1,060
TREVI THERAPEUTICS INC(TRVI)0163,738+163,73801,0300.92%+1,030
MBX BIOSCIENCES INC(MBX)0133,113+133,11309820.88%+982
NEKTAR THERAPEUTICS(NKTR)618,1742,232,453+1,614,2795751,5181.36%+943
GUARDANT HEALTH INC(GH)147,800127,182-20,6184,5155,4184.85%+903
89BIO INC225,323353,882+128,5591,7622,5732.30%+811
FULCRUM THERAPEUTICS INC(FULC)283,599689,137+405,5381,3331,9851.78%+652
BIOCRYST PHARMACEUTICALS INC(BCRX)060,600+60,60004550.41%+455
PENUMBRA INC(PEN)9,0009,00002,1372,4072.16%+269
GOSSAMER BIO INC(GOSS)1,097,9991,097,99909931,2081.08%+215
NUVATION BIO INC(NUVB)096,311+96,31101700.15%+170
SAVARA INC(SVRA)699,698836,397+136,6992,1482,3172.08%+169
AKEBIA THERAPEUTICS INC(AKBA)205,956189,087-16,8693913630.33%-28
KARYOPHARM THERAPEUTICS INC2,000,0002,000,00001,5561,5231.36%-34
ESTABLISHMENT LABS HLDGS INC(ESTA)13,10013,10006045350.48%-69
SYNDAX PHARMACEUTICALS INC(SNDX)318,900337,198+18,2984,2164,1423.71%-73
BEIGENE LTD(ONC)10,0006,500-3,5001,8471,7691.58%-78
ARBUTUS BIOPHARMA CORP(ABUS)28,3000-28,300930—-93
BIOHAVEN LTD(BHVN)28,15939,900+11,7411,0529590.86%-93
MERSANA THERAPEUTICS INC172,9240-172,9242500—-250
CENTESSA PHARMACEUTICALS PLC137,716142,744+5,0282,3072,0531.84%-254
LEAP THERAPEUTICS INC(CYPH)102,6310-102,6312950—-295
MADRIGAL PHARMACEUTICALS INC(MDGL)9870-9873050—-305
DR REDDYS LABS LTD(RDY)117,500117,50001,8551,5501.39%-305
ALVOTECH(ALVO)90,10090,10001,1928710.78%-321
APREA THERAPEUTICS INC(APRE)127,96028,972-98,988420590.05%-361
SOLENO THERAPEUTICS INC77,28543,441-33,8443,4743,1042.78%-370
VYNE THERAPEUTICS INC(YARW)353,434462,801+109,3671,1847310.65%-453
GERON CORP(GERN)1,561,1523,215,457+1,654,3055,6235,1134.58%-510
EDGEWISE THERAPEUTICS INC(EWTX)81,47371,438-10,0352,1751,5721.41%-604
SCHOLAR ROCK HLDG CORP(SRRK)77,43984,339+6,9003,3472,7112.43%-635
ELEDON PHARMACEUTICALS INC(ELDN)256,373114,145-142,2281,0563870.35%-669
INTUITIVE SURGICAL INC7,4276,358-1,0693,8773,1492.82%-728
ACELYRIN INC234,4350-234,4357360—-736
VERU INC(VERU)1,117,6000-1,117,6007400—-740
ANNEXON INC(ANNX)144,8300-144,8307430—-743
NATERA INC(NTRA)22,45018,650-3,8003,5542,6372.36%-917
ACLARIS THERAPEUTICS INC(ACRS)389,3330-389,3339660—-966
BRIDGEBIO PHARMA INC(BBIO)246,700165,496-81,2046,7695,7215.12%-1,048
TECTONIC THERAPEUTIC INC(TECX)26,0810-26,0811,2040—-1,204
LEGEND BIOTECH CORP(LEGN)37,6000-37,6001,2240—-1,224
STOKE THERAPEUTICS INC(STOK)113,0960-113,0961,2470—-1,247
DISC MEDICINE INC(IRON)69,07261,656-7,4164,3793,0612.74%-1,319
PLIANT THERAPEUTICS INC(PLRX)103,5040-103,5041,3630—-1,363
TARSUS PHARMACEUTICALS INC(TARS)28,1780-28,1781,5600—-1,560
ROCKET PHARMACEUTICALS INC(RCKT)159,5520-159,5522,0060—-2,006
JANUX THERAPEUTICS INC(JANX)40,1230-40,1232,1480—-2,148
SUMMIT THERAPEUTICS INC(SMMT)130,4120-130,4122,3270—-2,327
STRUCTURE THERAPEUTICS INC151,965102,944-49,0214,1211,7821.60%-2,339
ELI LILLY & CO(LLY)8,2474,673-3,5746,3673,8593.46%-2,507
GILEAD SCIENCES INC(GILD)29,7000-29,7002,7430—-2,743
BLUEPRINT MEDICINES CORP31,8000-31,8002,7740—-2,774
ARVINAS INC(ARVN)218,700195,295-23,4054,1921,3711.23%-2,822
NUVALENT INC40,5800-40,5803,1860—-3,186
BOSTON SCIENTIFIC CORP(BSX)40,5000-40,5003,6170—-3,617
BRISTOL-MYERS SQUIBB CO(BMY)65,2000-65,2003,6880—-3,688
APELLIS PHARMACEUTICALS INC
COM
119,4670-119,4673,8120—-3,812
RELAY THERAPEUTICS INC(RLAY)1,083,4870-1,083,4874,4640—-4,464
HUMANA INC(HUM)18,0660-18,0664,5840—-4,584
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q1 2025 | TickerTrail